HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JNM Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Choi, J. Y. Articles by Kim, B.-T. Search for Related Content PubMed PubMed Citation Articles by Choi, J. Y. Articles by Kim, B.-T.

Focal Thyroid Lesions Incidentally Identified by Integrated ¹⁸F-FDG PET/CT: Clinical Significance and Improved Characterization

¹ Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea; ² Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea; ³ Department of Thoracic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea; ⁴ Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea; and ⁵ Department of Otorhinolaryngology–Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

Correspondence: For correspondence or reprints contact: Byung-Tae Kim, MD, Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Ilwon-dong, Kangnam-ku, Seoul, Korea 135-710. E-mail: btnm.kim{at}samsung.com

In this retrospective study, we investigated whether the ¹⁸F-FDG uptake pattern and CT findings improved the accuracy over the standardized uptake value (SUV) for differentiating benign from malignant focal thyroid lesions incidentally found on ¹⁸F-FDG PET/CT. We also defined the prevalence of these lesions and their risk for cancer. Methods: ¹⁸F-FDG PET/CT was performed on 1,763 subjects without a previous history of thyroid cancer from May 2003 to June 2004. Two nuclear medicine physicians and 1 radiologist interpreted PET/CT images, concentrating on the presence of focal thyroid lesions, the maximum SUV of the thyroid lesion, the pattern of background thyroid ¹⁸F-FDG uptake, and the CT attenuation pattern of the thyroid lesion. Results: The prevalence of focal thyroid lesions on PET/CT was 4.0% (70/1,763). Diagnostic confirmation was done on 44 subjects by ultrasonography (US)-guided fine-needle aspiration (n = 29) or US with clinical follow-up (n = 15). Among 49 focal thyroid lesions in these 44 subjects, 18 focal thyroid lesions of 17 subjects were histologically proven to be malignant (papillary cancer in 16, metastasis from esophageal cancer in 1, non–Hodgkin's lymphoma in 1). Therefore, the cancer risk of focal thyroid lesions was 36.7% on a lesion-by-lesion basis or 38.6% on a subject-by-subject basis. The maximum SUV of malignant thyroid lesions was significantly higher than that of benign lesions (6.7 ± 5.5 vs. 10.7 ± 7.8; P < 0.05). When only the maximum SUV was applied to differentiate benign from malignant focal thyroid lesions for the receiver-operating-characteristic curve analysis, the area under the curve (AUC) of PET was 0.701. All 16 focal thyroid lesions with very low attenuation or nonlocalization on CT images, or with accompanying diffusely increased thyroid ¹⁸F-FDG uptake, were benign. When those lesions were regarded as benign lesions, irrespective of the maximum SUV, the AUC of PET/CT was significantly improved to 0.878 (P < 0.01). Conclusion: Focal thyroid lesions incidentally found on ¹⁸F-FDG PET/CT have a high risk of thyroid malignancy. Image interpretation that includes ¹⁸F-FDG uptake and the CT attenuation pattern, along with the SUV, significantly improves the accuracy of PET/CT for differentiating benign from malignant focal thyroid lesions.

Key Words: thyroid • incidentaloma • PET/CT • PET • ¹⁸F-FDG

Related articles in JNM:

This Month in JNM

JNM 2006 47: 9a-10a. [Full Text]  

This article has been cited by other articles:

				J. Y. Kwak, E.-K. Kim, M. Yun, A. Cho, M. J. Kim, E. J. Son, and K. K. Oh Thyroid Incidentalomas Identified by 18F-FDG PET: Sonographic Correlation Am. J. Roentgenol., August 1, 2008; 191(2): 598 - 603. [Abstract] [Full Text] [PDF]

				M. J. Yeung and J. W. Serpell Management of the Solitary Thyroid Nodule Oncologist, February 1, 2008; 13(2): 105 - 112. [Abstract] [Full Text] [PDF]

				L. Giovanella, L. Ceriani, S. Crippa, and L. Mazzucchelli Langherans Cell Histiocytosis of the Thyroid Gland Detected by 18FDG-PET/CT J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 2866 - 2867. [Full Text] [PDF]

				D. Karantanis, T. V. Bogsrud, G. A. Wiseman, B. P. Mullan, R. M. Subramaniam, M. A. Nathan, P. J. Peller, R. S. Bahn, and V. J. Lowe Clinical Significance of Diffusely Increased 18F-FDG Uptake in the Thyroid Gland J. Nucl. Med., June 1, 2007; 48(6): 896 - 901. [Abstract] [Full Text] [PDF]

				A. Quon, N. J. Fischbein, I. R. McDougall, Q.-T. Le, B. W. Loo Jr., H. Pinto, and M. J. Kaplan Clinical Role of 18F-FDG PET/CT in the Management of Squamous Cell Carcinoma of the Head and Neck and Thyroid Carcinoma J. Nucl. Med., January 1, 2007; 48(1_suppl): 58S - 67S. [Abstract] [Full Text] [PDF]